semaglutide and insulin combination Added to Basal in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial What Is the Potential Role
Description
However, staying attuned to systemic health trends is equally critical, especially with the rise of GLP-1 receptor agonists (like semaglutide and liraglutide) in managing diabetes and obesity.
The recent approval of OZEMPIC reinforces the growing trend of GLP-1 drugs being used for conditions beyond diabetes and weight loss.
Stopping semaglutide after weight loss requires careful planning
Several animal models showed that treatment with GLPs may lead to improvement of colitis
Read more: Photo: Michael
